ETF constituents for IBRN

Below, a list of constituents for IBRN (iShares Neuroscience and Healthcare ETF) is shown. In total, IBRN consists of 69 securities.

Note: The data shown here is as of date Mar 31, 2025 (the latest that can be sourced directly from the fund provider).

Click here to go back to the full list of ETFs.

Ticker Name Sector Asset Class Market Value Weight (%)
CPRX CATALYST PHARMACEUTICALS INC Health Care Equity 158177.4 4.95
ARGX ARGENX SE ADR Health Care Equity 155366.33 4.86
XENE XENON PHARMACEUTICALS INC Health Care Equity 154596.57 4.84
326030 SK BIOPHARMACEUTICALS LTD Health Care Equity 152414.74 4.77
PTCT PTC THERAPEUTICS INC Health Care Equity 140859.37 4.41
NBIX NEUROCRINE BIOSCIENCES INC Health Care Equity 138366.4 4.33
SRRK SCHOLAR ROCK HOLDING CORP Health Care Equity 135102.8 4.23
DNLI DENALI THERAPEUTICS INC Health Care Equity 134422.2 4.21
SUPN SUPERNUS PHARMACEUTICALS INC Health Care Equity 128541.12 4.02
ACAD ACADIA PHARMACEUTICALS INC Health Care Equity 125576.85 3.93
ALKS ALKERMES Health Care Equity 121344.36 3.8
BIIB BIOGEN INC Health Care Equity 121267.8 3.8
BHVN BIOHAVEN LTD Health Care Equity 108837.9 3.41
HLUN B H. LUNDBECK CLASS B Health Care Equity 88595.16 2.77
SRPT SAREPTA THERAPEUTICS INC Health Care Equity 88490.52 2.77
IART INTEGRA LIFESCIENCES HOLDINGS CORP Health Care Equity 80982.56 2.53
EWTX EDGEWISE THERAPEUTICS INC Health Care Equity 71059.56 2.22
4592 SANBIO LTD Health Care Equity 66485.7 2.08
DYN DYNE THERAPEUTICS INC Health Care Equity 65019.51 2.03
AVXL ANAVEX LIFE SCIENCES CORP Health Care Equity 59321.61 1.86
NEU NEUREN PHARMACEUTICALS LTD Health Care Equity 58254.51 1.82
AVDL AVADEL PHARMACEUTICALS ORD Health Care Equity 57029.92 1.78
BIOA B BIOARCTIC CLASS B Health Care Equity 56919.02 1.78
PRAX PRAXIS PRECISION MEDICINES INC Health Care Equity 52638.74 1.65
AXGN AXOGEN INC Health Care Equity 50425.24 1.58
DYVOX DYNAVOX GROUP Information Technology Equity 43810.5 1.37
CAPR CAPRICOR THERAPEUTICS INC Health Care Equity 43322.91 1.36
DNTH DIANTHUS THERAPEUTICS INC Health Care Equity 33657.93 1.05
PRTA PROTHENA PLC Health Care Equity 31606.02 0.99
ZVRA ZEVRA THERAPEUTICS INC Health Care Equity 30124.51 0.94
MEDCL MEDINCELL SA Health Care Equity 28334.38 0.89
RGNX REGENXBIO INC Health Care Equity 27244.88 0.85
AMLX AMYLYX PHARMACEUTICALS INC Health Care Equity 24909.96 0.78
CLPT CLEARPOINT NEURO INC Health Care Equity 23923.2 0.75
CBLL CERIBELL INC Health Care Equity 23277.52 0.73
TSHA TAYSHA GENE THERAPIES INC Health Care Equity 22127.18 0.69
2172 MICROPORT NEUROTECH CORP Health Care Equity 21242.59 0.66
NPCE NEUROPACE INC Health Care Equity 19363.8 0.61
NGNE NEUROGENE INC Health Care Equity 18960.93 0.59
VNDA VANDA PHARMACEUTICALS INC Health Care Equity 18768.96 0.59
DRUG BRIGHT MINDS BIOSCIENCES INC Health Care Equity 18425.0 0.58
IDIA IDORSIA N LTD Health Care Equity 16767.34 0.52
ABEO ABEONA THERAPEUTICS INC Health Care Equity 16172.64 0.51
RAPP RAPPORT THERAPEUTICS INC Health Care Equity 16146.9 0.51
SLDB SOLID BIOSCIENCES INC Health Care Equity 16093.56 0.5
TRDA ENTRADA THERAPEUTICS INC Health Care Equity 15172.82 0.47
SANN SANTHERA N AG Health Care Equity 14983.6 0.47
FULC FULCRUM THERAPEUTICS INC Health Care Equity 14260.55 0.45
ANNX ANNEXON INC Health Care Equity 13351.36 0.42
VYGR VOYAGER THERAPEUTICS INC Health Care Equity 12125.26 0.38
SGMO SANGAMO THERAPEUTICS INC Health Care Equity 11450.42 0.36
DSGN DESIGN THERAPEUTICS INC Health Care Equity 9024.84 0.28
LRMR LARIMAR THERAPEUTICS INC Health Care Equity 6423.62 0.2
ALEC ALECTOR INC Health Care Equity 6133.86 0.19
CLYM CLIMB BIO INC Health Care Equity 5955.84 0.19
USD USD CASH Cash and/or Derivatives Cash 4949.9 0.15
SAVA CASSAVA SCIENCES INC Health Care Equity 4940.13 0.15
CTNM CONTINEUM THERAPEUTICS INC CLASS A Health Care Equity 4895.1 0.15
ANRO ALTO NEUROSCIENCE INC Health Care Equity 4452.2 0.14
CHF CHF CASH Cash and/or Derivatives Cash 1085.35 0.03
DKK DKK CASH Cash and/or Derivatives Cash 476.69 0.01
AUD AUD CASH Cash and/or Derivatives Cash 397.23 0.01
EUR EUR CASH Cash and/or Derivatives Cash 235.92 0.01
SEK SEK CASH Cash and/or Derivatives Cash 173.8 0.01
KRW KRW CASH Cash and/or Derivatives Cash 121.9 0.0
JPY JPY CASH Cash and/or Derivatives Cash 65.16 0.0
HKD HKD CASH Cash and/or Derivatives Cash 20.7 0.0
MARGIN_USD FUTURES USD MARGIN BALANCE Cash and/or Derivatives Cash Collateral and Margins 0.63 0.0
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. nan nan nan nan nan